Prolensa Effective for the Treatment of Pain, Inflammation After Cataract Surgery
In the second of two phase 3 studies of bromfenac
ophthalmic solution (Prolensa; Ista Pharmaceuticals, Inc.)
for the treatment of pain and inflammation after cataract
surgery, the agent met the study’s primary and secondary
efficacy endpoints, according to a company news release.
Prolensa, which is a low concentratio...